Search

Recursion Pharmaceuticals Inc

Затворен

СекторЗдравеопазване

4 -8.26

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.93

Максимум

4.36

Ключови измерители

By Trading Economics

Приходи

-14M

-131M

Продажби

1.2M

7.7M

EPS

-0.25

Марж на печалбата

-1,708.018

Служители

600

EBITDA

-10M

-113M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+52.52% upside

Дивиденти

By Acuity

Следващи печалби

4.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

876M

2.6B

Предишно отваряне

12.26

Предишно затваряне

4

Recursion Pharmaceuticals Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.10.2026 г., 20:02 ч. UTC

Recursion Pharmaceuticals Inc shares are sharply lower, continuing a downward trend since Friday, despite an early spike in today's trading session.

10.10.2026 г., 00:01 ч. UTC

Recursion Pharmaceuticals Inc shares advanced during after-market hours on Friday, despite earlier pulling back from a session high.

9.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours, recovering from an earlier decline while remaining well above its 20-day moving average.

8.10.2026 г., 20:01 ч. UTC

News
Correlated Moves

Recursion Pharmaceuticals faces downward pressure amid significant insider transactions, including a 50k share sale by Director Borgeson Blake on October 6.

7.10.2026 г., 23:05 ч. UTC

Recursion Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of three consecutive sessions finishing lower since Wednesday's close.

6.10.2026 г., 20:02 ч. UTC

Correlated Moves
Social Media
News

Recursion Pharmaceuticals Inc. shares fell amid sector declines, with attention on upcoming Phase 2 data for REC-4881 and ongoing trials for other candidates.

5.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, continuing lower since Monday's close, despite remaining above its 20-day moving average.

2.10.2026 г., 20:07 ч. UTC

Correlated Moves

Recursion Pharmaceuticals Inc is trading higher, supported by a favorable market environment and positive sentiment following recent labor statistics.

1.10.2026 г., 23:01 ч. UTC

Recursion Pharmaceuticals Inc saw modest gains in after-market hours, reaching a peak increase before settling lower, remaining near the upper end of its one-month range.

30.09.2026 г., 23:30 ч. UTC

Correlated Moves

Recursion Pharmaceuticals Inc is trading higher in after-market hours, reflecting a broader market trend amid positive developments in technology and a revised U.S. GDP growth rate.

29.09.2026 г., 23:31 ч. UTC

Recursion Pharmaceuticals Inc shares declined modestly in after-market trading, moving lower from Tuesday's close, currently around 0.74%, but above its 20-day moving average.

28.09.2026 г., 19:35 ч. UTC

Social Media

Recursion Pharmaceuticals Inc shares fell amid commentary on its role in AI-driven drug design, reflecting a decline since Friday's close.

25.09.2026 г., 23:50 ч. UTC

Recursion Pharmaceuticals Inc has advanced in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month trading range.

24.09.2026 г., 20:07 ч. UTC

Correlated Moves

Recursion Pharmaceuticals is advancing amid a positive biotechnology trend, gaining alongside the ARK Genomic Revolution ETF, which benefits from favorable news from its holdings.

23.09.2026 г., 23:21 ч. UTC

Recursion Pharmaceuticals Inc is advancing in after-market trading, rising sharply since Wednesday's close and remaining above its 20-day moving average.

22.09.2026 г., 19:50 ч. UTC

Social Media

Recursion Pharmaceuticals' stock is advancing after extending a data license agreement with Tempus AI, involving $42 million in committed payments over three years.

21.09.2026 г., 23:30 ч. UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, contrasting with recent gains, though it remains above its 20-day moving average.

19.09.2026 г., 00:01 ч. UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, moving lower since Friday's close, with notable momentum shifts observed during the session.

18.09.2026 г., 23:41 ч. UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, moving lower since Friday's close, despite remaining significantly above its 20-day moving average.

17.09.2026 г., 23:01 ч. UTC

Correlated Moves

Recursion Pharmaceuticals Inc is trading modestly lower in after-market hours, moving in sympathy with Schrodinger Inc amid mixed economic indicators.

16.09.2026 г., 22:51 ч. UTC

Correlated Moves

Recursion Pharmaceuticals Inc is moving higher in after-market trading, reflecting broader market gains following a sharp rise in U.S. retail sales in August.

15.09.2026 г., 23:02 ч. UTC

Recursion Pharmaceuticals Inc. shares are higher in after-market trading, following the broader market's upward trend despite no specific company news.

14.09.2026 г., 20:08 ч. UTC

Correlated Moves

Recursion Pharmaceuticals is gaining today, benefiting from Schrödinger's collaboration agreement with Tectora Therapeutics. Earlier, shares pulled back but have since recovered.

11.09.2026 г., 19:46 ч. UTC

Recursion Pharmaceuticals Inc shares are higher during Friday's session, despite a slight pullback from earlier highs. No specific news was identified for the move.

10.09.2026 г., 23:16 ч. UTC

No specific news was identified for Recursion Pharmaceuticals Inc. during after-market hours. The stock remained roughly flat since Thursday's close.

9.09.2026 г., 23:06 ч. UTC

Recursion Pharmaceuticals Inc shares are higher in after-market trading, following a notable peak earlier in the session with no specific news identified.

8.09.2026 г., 22:51 ч. UTC

Recursion Pharmaceuticals Inc shares are higher in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

4.09.2026 г., 20:08 ч. UTC

Recursion Pharmaceuticals shares are higher today, continuing an upward trend since Thursday's close, amid broader market dynamics following a strong jobs report.

3.09.2026 г., 23:21 ч. UTC

Correlated Moves

Recursion Pharmaceuticals Inc. shares declined in after-market trading, following a peak shortly after the market closed and amid broader market weakness.

2.09.2026 г., 23:06 ч. UTC

Recursion Pharmaceuticals Inc shares are lower in after-market trading. The decline comes amid a weaker ADP private payrolls report impacting overall market sentiment.

Сравнение с други в отрасъла

Ценова промяна

Recursion Pharmaceuticals Inc Прогноза

Ценова цел

By TipRanks

52.52% нагоре

12-месечна прогноза

Среден 6.65 USD  52.52%

Висок 8 USD

Нисък 5.3 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Recursion Pharmaceuticals Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

2

Купи

3

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.